Connecticut Eases Coronavirus Restrictions

As of Thursday, the state had 433 people hospitalized with the virus. Its average positive test rate over the past seven days is at 2.3 percent, which Mr. Lamont said was the lowest rate in nearly four months.

“We’re beginning to get a handle on what works,” he said, pointing to the decline.

Still, over the past week, Connecticut has reported an average of 22 new virus cases a day per 100,000 people, a rate that is the 10th highest per capita among all states.

The United States as a whole is averaging 19 new daily cases per 100,000 people. Federal health officials, including the head of the Centers for Disease Control and Prevention, have urged governors not to relax their rules, warning that the country may be leveling off at a relatively high number of daily virus cases.

But Mr. Lamont said that he did not believe that the capacity limits on businesses were having a significant enough effect on curbing the virus that they needed to remain in place.

“It’s not so much a question of how you adjust the dial and go ‘capacity up 10 percent’ or ‘down 10 percent,’ or whether you have a curfew for two weeks or four weeks, and then you go back,” Mr. Lamont said. “I think we’re finding what works is wearing the mask, social distancing and vaccinations.”

Mr. Lamont’s announcement reflected decisions by other states to loosen virus-related restrictions as vaccination programs were ramping up and the number of new cases were starting to plateau. Throughout the pandemic, officials have had to adjust restrictions, finding a balance between safety, economic concerns and political pressure.

The governors of New York and New Jersey, both also Democrats, with whom Mr. Lamont has collaborated significantly on the pandemic response, have raised capacity limits in businesses, including restaurants, in the past month. Both of those states have been reporting new cases at the highest rates in the country.

View Source

A college president wanted a firsthand look at dorm lockdown. Very firsthand.

Derek Furtado, a sophomore at Norwich University, had just stepped out of the shower in his dormitory and was shaving, a towel wrapped around his waist, when he looked to his left and saw the figure of a man in military uniform.

“That was when my heart sunk,” recalled Mr. Furtado, a cadet who plans to commission into the Coast Guard. He pulled himself together, stood at attention and said, “Good morning, sir!” The circumstances were not ideal. “He has two stars on his chest,” Mr. Furtado said. “I’m in a towel.”

But he would have to get used to it, because, it turned out, Col. Mark C. Anarumo, the university’s president, was his new hall mate.

Among the surprising outcomes of the coronavirus pandemic was that Dr. Anarumo, newly arrived as president of the private military college in Vermont, decided that the best way to support students who were quarantining in their rooms was to move into the dorm with them.

some parents lashed out, the administration relaxed the measures, allowing seniors to double up in rooms and leave campus for meals. The Academy’s leaders revisited their earlier decisions, reconsidering the risks of isolation, said Dr. Anarumo, who has a Ph.D. in criminal justice.

estimated 26 million college students whose lives have been disrupted by the virus.

“We’re enforcing physical loneliness,” said Dr. Rachel C. Conrad, the director of Young Adult Mental Health at Brigham and Women’s Hospital in Boston. “There’s not really anything to compare it to, exactly, from our history.”

View Source

In New York, as shoppers went online, Amazon went on a warehouse-buying spree.

As the pandemic gripped New York City, it propelled an enormous surge in online shopping. Amazon, the giant online retailer, went shopping too.

Amazon has spent the pandemic embarking on a warehouse shopping spree in New York, significantly expanding its footprint.

It has snatched up at least nine new warehouses in the city, including a behemoth rising in Queens that, at one million-plus square feet, will be its largest in New York, and today has at least 12 warehouses in the five boroughs. And it has added more than two dozen warehouses in suburbs surrounding the city.

No other large competitor has a single warehouse in the city and Amazon has largely left most of its chief rivals, like Walmart and Target, behind.

a gleaming new headquarters in Long Island City, Queens.

New York has about 128 million square feet of industrial space, far less than many smaller cities (not to mention narrow streets and a brutal lack of parking).

Many packages come to New York from New Jersey and Pennsylvania, where there is room to build bigger and cheaper warehouses. And in the past year, Amazon has added 14 new warehouses in New Jersey and on Long Island, totaling more than seven million square feet.

But having warehouses in the city is more cost effective and can trim roughly 20 percent off delivery expenses compared with deliveries that originate in New Jersey. Amazon, which owns Whole Foods, has also used the grocery stores to fulfill online orders, with its workers often outnumbering store customers.

Roughly 2.4 million packages are delivered in New York City every day, nearly half a million more than before the pandemic, and city data shows that 80 percent of deliveries are to residential customers, compared with 40 percent before the outbreak.

“We are excited to continue to invest in the state of New York by adding new delivery stations,” said Deborah Bass, an Amazon spokeswoman, adding that the company’s goal was to “become part of the fabric of New York City by embracing the people, the needs, and the spirit of the community.”

View Source

India’s Covaxin shots could be effective and safe, interim trial results suggest.

India’s ambitious but troubled campaign to inoculate its vast population against Covid-19 — and, in the process, to burnish its reputation as a manufacturer and innovator — received a major lift after initial trial results showed a homegrown vaccine was safe and effective.

Bharat Biotech, the Indian drug company that developed the shots, said late Wednesday that early findings from clinical trials involving nearly 26,000 subjects showed that the vaccine, Covaxin, had an initial efficacy rate of 81 percent.

The results have yet to be peer reviewed, the company said, and it was unclear how effective Covaxin would prove to be in a final analysis.

Still, the results were met with relief in India. Covaxin was approved by government officials in January and administered to millions of people even though it had not yet been publicly proved. Many in the country, including frontline health care workers, had feared that Covaxin could be ineffective or worse, slowing down the national campaign to inoculate 1.3 billion people.

approved Covaxin for emergency use in early January along with the Oxford-AstraZeneca vaccine, which is known in India as Covishield. When the vaccination drive started less than two weeks later, most people were not allowed to choose which shot they got.

sharp criticism from pharmaceutical bodies and health experts, who questioned the scientific logic behind approving a vaccine that was still in trials. Indian officials often denounced those doubts without explaining the rush. Instead, they portrayed the endorsement of Covaxin through a lens of nationalism, saying that it showed India’s emergence as a scientific power.

View Source